Compound Detail
CHEMBL1432676
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL1432676 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | WOLJNABPEMDNLM-UHFFFAOYSA-N |
| Parent Compound | CHEMBL1620776 |
| Active Moiety | CHEMBL1620776 |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
0
Publications
0
Known Names
Molecular Properties
305.5
MW (Da)
4.73
ALogP
1
HBA
0
HBD
3.2
PSA (Ų)
0.70
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 5.21
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Neuropeptide Y receptor type 2 CHEMBL4018 | IC50 | 5.21 | 5.21 | 6166.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Neuropeptide Y receptor type 2 | IC50 | = | 6166.0 | nM | 5.21 | PUBCHEM_BIOASSAY: Dose response cell-based screening assay for antagonists of ne... | - |
Data from ChEMBL 36 via Core Engine